Vycor Medical (VYCO) Total Current Liabilities (2010 - 2026)
Vycor Medical (VYCO) reported Total Current Liabilities of $4.9 million for Q1 2026, up 6.33% year-over-year from $4.7 million in Q1 2025, and up 3.48% quarter-over-quarter from $4.8 million in Q4 2025.
Vycor Medical (VYCO) Total Current Liabilities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Total Current Liabilities data on file, last reported at $4.9 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $4.9 million, up 6.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 million (up 6.33% YoY), and the FY2025 annual result was $4.8 million, up 6.34% from the prior year.
- Total Current Liabilities improved to $4.9 million in Q1 2026 per VYCO's latest filing, from $4.8 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $4.9 million in Q1 2026 and troughed at $3.4 million in Q1 2022.
- A 5-year average of $4.2 million and a median of $4.3 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities grew 16.58% in 2022, then rose 5.76% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $3.7 million in 2022, then gained by 11.48% to $4.1 million in 2023, then gained by 10.36% to $4.5 million in 2024, then increased by 6.34% to $4.8 million in 2025, then climbed by 3.48% to $4.9 million in 2026.
- Business Quant data shows VYCO's Total Current Liabilities at $4.9 million in Q1 2026, $4.8 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Vycor Medical | - | - | 375,153.00 | 4.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.95 Mn |
| Dec 31, 2025 | 4.78 Mn |
| Sep 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.55 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 4.07 Mn |
| Sep 30, 2023 | 4.03 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.36 Mn |
| Mar 31, 2022 | 3.35 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 3.11 Mn |
| Jun 30, 2021 | 3.04 Mn |